Prne
September 27th, 2009
DUBAI, UAE - Neopharma, the Abu Dhabi-based pharmaceuticals manufacturer, today announced it has received clearance from the UAE Ministry of Health for the production of an antiviral medication Oseltamivir BR Flu.
The approval comes at a time when the entire region is stepping up efforts to tackle the H1N1 pandemic. The drug is a potential choice to prevent and treat H1N1 flu in the region.
His Excellency Abdulla Humaid Al Mazroei, Vice-Chairman, Neopharma, and Dr. B.R. Shetty, Managing Director and CEO, thanked the UAE Ministry of Health on behalf of the Board of Directors of the company.
Dr. Shetty said: “The endorsement for the antiviral drug to be manufactured by Neopharma reflects the strong support of the Ministry of Health for the vision of the UAE leadership to create a self-sustaining community. As a leading manufacturer of life-saving drugs, we believe it is our responsibility to play a vital role in helping the community at this critical juncture.
“We are confident the approval for Oseltamivir will significantly facilitate medical professionals and the wider community to effectively combat the lethal H1N1 virus in the region.”
Neopharma’s Oseltamivir BR Flu is the outcome of a joint venture with leading pharmaceuticals major Hetero Drugs Ltd and is the first in a series of major life-saving drugs the company plans to produce over the next few years.
Currently, Neopharma has independent production blocks for the manufacture of general and betalactam products. The company’s plant in Abu Dhabi is designed for the large-scale production of tablets, capsules and liquid orals.
About Neopharma:
Neopharma is a premier pharmaceuticals manufacturing company based in Abu Dhabi. Set up in October 2003, Neopharma manufactures a wide range of products including antibiotics, analgesics, respiratory medicines, antihistamines, as well as medications for cardiovascular conditions and diabetes. A robust R&D centre, hi-tech manufacturing and quality embedded operations make the company a manufacturer of world-class pharmaceutical products.
Neopharma has received the prestigious Mohammed bin Rashid Al Maktoum Award in the manufacturing category and is also the recipient of the current European Good Manufacturing Practice Guidelines Certification from Belgium. The company has received the ISO 9001, ISO 14,001 and OHSAS 18,001 certifications for integrated management system encompassing quality, environment and safety standards.
For further information, please call: Zeba Ahmad JiWin Tel: +9714-361-3590 e-mail: Zeba.Ahmad@jiwin.ae
Source: Neopharma
For further information, please call: Zeba Ahmad, JiWin, Tel: +9714-361-3590, e-mail: Zeba.Ahmad at jiwin.ae
Filed under Business, Clinical Trials / Medical Discoveries, Health, Health Care / Hospitals, Infectious Disease Control, New Products / Services, Pharmaceuticals | Tags: Dubai, Middle East, Neopharma, uae | Comment Below
Related Press Releases Neopharma Expands Into Biotechnology and Nanotechnology-Based Research and DevelopmentOctober 5th, 2009 DUBAI, UAE - Neopharma, the Abu Dhabi-based pharmaceuticals manufacturer, has ventured into biotechnology and nanotechnology-based research and manufacturing capabilities. The announcement came at a press conference that was preceded by a ground breaking ceremony held under the patronage and in the presence of His Highness Sheikh Nahyan bin Mubarak Al Nahyan, UAE Minister for Higher Education and Scientific Research, and Chairman of Neopharma. 30th Anniversary Edition of Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases is More Relevant Than EverSeptember 23rd, 2009 PHILADELPHIA, Pennsylvania -
- Highly Respected Text Addresses New Strains of the Swine (H1N1) and Avian Influenza Viruses. Elsevier, the world-leading publisher of scientific, technical and medical information products and services, proudly announces the release of Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 7th Edition. Elsevier Global Medical News Launches H1N1 ChannelAugust 17th, 2009 MORRISTOWN, New Jersey - An H1N1 influenza channel has been added to the Elsevier Global Medical News (EGMN) wire service division of the International Medical News Group. The H1N1 channel was created to meet physicians' continuing needs to keep up-to-date with the news about the spread of the 2009 H1N1 influenza virus, as well as the new diagnostics, vaccines, clinical trials, and treatments for H1N1 infections. NanoPass Makes its MicronJet Technology Available to Increase Global Supply of Pandemic Influenza VaccinesAugust 12th, 2009 NES ZIONA, Israel -
- Intradermal Delivery of Vaccines can Provide Significant Dose Sparing Urgently Required in the Swine H1N1 Pandemic
Following the World Health Organization (WHO) declaration of a swine flu pandemic,[1] NanoPass Technologies Ltd. (NanoPass) announced today that it has successfully developed a microneedle-based injection device that could dramatically enhance both the effectiveness and supply of pandemic flu vaccines. Royal Pharmaceutical Society Calls for Older People to Review Their Medicine With a PharmacistJuly 28th, 2009 LONDON -
New research released today by the Royal Pharmaceutical Society of Great Britain (RPSGB) reveals how older people are taking a cocktail of medicine without fully understanding what they are or the side effects they are causing. The RPSGB survey shows that nearly half (43%) of over 65's are currently taking over five medicines at any one time. New Hand Sanitiser Proven to be Effective Against H1N1 Flu VirusApril 30th, 2009 LONDON - A new alcohol-free hand sanitiser, SOAPOPULAR, which has been recently launched in the UK may be the first line of defence against the spread of swine flu claims its Canadian manufacturers. Says Steven Orrett, CEO of SOAPOPULAR inc, based in Toronto, Canada, "the best defense is proper hand hygiene and hand washing - where water is not present or available, using SOAPOPULAR is the best option for not only killing germs that you come in contact with, but stopping the spread of viruses and infectious diseases."
SOAPOPULAR differs from most hand sanitisers currently available in the UK as it does not use alcohol as its main active ingredient, making it a safer option especially for children. Plasma Products Safe Despite Swine Influenza Outbreak, Assures International Biopharmaceutical Company OctapharmaApril 30th, 2009 LACHEN, Switzerland - Company Working With Authorities to Ensure Adequate Supply of Virally Inactivated Plasma Derivatives
The impending influenza pandemic will have implications for global stocks of life-saving blood and blood products, warns Swiss-based global biopharmaceutical company, Octapharma. But it has reiterated the safety of its plasma derivatives and is working closely with health authorities and plasma suppliers to maintain the safety profile and continuous supply of its lifesaving products. Are we Ignoring H2N3 at our Peril?April 30th, 2009 LONDON - Everyone is Blaming H1N1, but Could a Different Strain of Influenza be the Cause of Mexican Deaths? Clinica - The Medical Technology Industry's Leading News Source - Wonders What Implications This Would Have for Mexico and the Rest of the World
Clinica is investigating the details and significance of Mexican health ministry statements that the H2N3 influenza virus was responsible for "the majority of cases tested" in an influenza outbreak in early April, three weeks before H1N1 came on the scene. The existence of an additional strain of the disease raises fundamental questions concerning the management of the swine flu epidemic internationally. Arrayit to Mass Produce Rapid H1N1 Swine Flu Test ChipApril 29th, 2009 SUNNYVALE, California - Arrayit Corporation (OTC Bulletin Board: ARYC), a leading manufacturer of products and services for disease prevention, treatment and cure, announced today that it is developing a microarray-based diagnostic test to detect the H1N1 swine flu virus. The Arrayit test will allow researchers and clinicians to detect the presence of the virus in infected patients and livestock and to distinguish the threatening mutated strain from less harmful variants in humans and swine. Finland Seeks Systemic Changes in Health CareMarch 25th, 2009 HELSINKI - The report entitled The Finnish Health Care System: A Value-Based
Perspective highlights new strategic perspectives on the development needs of
health care in Finland. The report utilizes Michael E.
Related News Cuba confirms first swine flu caseMay 12th, 2009 HAVANA - A Mexican student in Cuba has tested positive for the H1N1 flu virus, making him the first person confirmed to have swine flu on the Caribbean island, the health ministry said. 'As of now, there is one confirmed case of the A(H1N1) influenza virus, (according to) the diagnosis made by the Institute of Tropical Medicine,' Cuban television reported, citing a health ministry communique. India's first Swine Flu patient shows improvementMay 17th, 2009 HYDERABAD - Doctors at the Chest Hospital in Hyderabad have declared that the symptoms of India's first confirmed swine flu patient have come down after he started receiving medication. Doctors at the Swine Flu Isolation Ward said the hospital was taking every precaution to ensure that the H1N1 virus does not spread any further, and that there is no need for the general public to panic. Mexico swine flu toll reaches 70May 19th, 2009 MEXICO CITY - The number of confirmed deaths from influenza A (H1N1) in Mexico has risen to 70, with total confirmed infections by the virus reaching 3,646, the country's health ministry has said. 'Two deaths that took place on April 19 and May 13 in Mexico City were confirmed to be related to the A/H1N1 flu,' the ministry's statement said Monday. Warm weather may not halt swine fluMay 10th, 2009 WASHINGTON - New data from Mexico and case numbers so far suggest that if the spread of H1N1 "swine flu" continues elsewhere as it has in the Americas, the virus could infect more than a billion people by July. The data also suggests that summer temperatures in temperate countries may not slow the virus. First human-to-pig case of flu reported in CanadaMay 3rd, 2009 TORONTO - With swine flu cases rising sharply to 85, Canadian authorities Saturday confirmed the first case where pigs contracted the H1N1 virus from a man who had just returned from Mexico. The Canadian Food Inspection Agency said this could be first case of human-to-animal transmission of the virus during the current global outbreak. Got the flu? Toot three timesMay 4th, 2009 WELLINGTON - New Zealand health officials have told people who suspect they may have swine flu to sound their car horn outside a doctor's clinic three times and wait for help, a newspaper reported Monday. The 'toot three times' policy outlined in a flu management protocol would give doctors or nurses time to protect themselves before escorting patients into isolation, the New Zealand Herald reported. Over 1,800 swine flu cases, 31 deaths: WHOMay 7th, 2009 GENEVA - The number of laboratory confirmed cases of infections of the new influenza A(H1N1) virus rose to 1,893 in 23 countries, the World Health Organization said. In a posting to its website late Wednesday, the health agency confirmed also a second death in the US, on top of 29 deaths in Mexico. Mexico denies hiding information on fluMay 13th, 2009 MEXICO CITY/HAVANA - Mexican President Felipe Calderon has said that the A(H1N1) influenza epidemic has been dealt with transparently from the first instance it became known to the country's authorities. Calderon did not mention Cuban leader Fidel Castro, who had accused Mexico of not telling other countries earlier about the ongoing influenza epidemic due to the visit of US President Barack Obama. Ecuador, Turkey confirm swine flu infectionsMay 16th, 2009 MEXICO CITY - Ecuador and Turkey have confirmed their first cases of swine flu infections. The number of countries affected by the swine flu in Latin America has risen to 12 after Ecuador reported its first infection Friday. China develops new method to test swine flu in pigsMay 4th, 2009 BEIJING - China has developed a new diagnostic method to test influenza A(H1N1) virus in pigs, the agriculture ministry said. Officials said the new method can deliver test results within five hours.
|
|